BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 21833476)

  • 1. FaDu cell characteristics induced by multidrug resistance.
    Ma J; Lu S; Yu L; Tian J; Li J; Wang H; Xu W
    Oncol Rep; 2011 Nov; 26(5):1189-95. PubMed ID: 21833476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of ABCB1 and ABCG2 in the multidrug resistance of hypopharyngeal carcinoma FaDu cell line].
    MA JK; LU SM; YU L; TIAN JJ; LI JF; WANG HB; XU W
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 47(4):305-10. PubMed ID: 22800348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MG132 reverse the malignant characteristics of hypopharyngeal cancer.
    Ma J; Yu L; Tian J; Mu Y; Lv Z; Zou J; Li J; Wang H; Xu W
    Mol Med Rep; 2014 Jun; 9(6):2587-91. PubMed ID: 24691740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrandrine enhances cytotoxicity of cisplatin in human drug-resistant esophageal squamous carcinoma cells by inhibition of multidrug resistance-associated protein 1.
    Wang TH; Wan JY; Gong X; Li HZ; Cheng Y
    Oncol Rep; 2012 Nov; 28(5):1681-6. PubMed ID: 22941407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells.
    Svirnovski AI; Shman TV; Serhiyenka TF; Savitski VP; Smolnikova VV; Fedasenka UU
    Hematology; 2009 Aug; 14(4):204-12. PubMed ID: 19635183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance.
    Li G; Chen X; Wang Q; Xu Z; Zhang W; Ye L
    J Huazhong Univ Sci Technolog Med Sci; 2007 Apr; 27(2):173-5. PubMed ID: 17497289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation of chemosensitivity measured by histoculture drug response assay to expression of multidrug resistance genes and proteins in gastric cancer].
    Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Keshari RP; Zhang LY
    Ai Zheng; 2009 Apr; 28(4):337-43. PubMed ID: 19622290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MG‑132 reverses multidrug resistance by activating the JNK signaling pathway in FaDu/T cells.
    Ma J; Lv Z; Liu X; Liu X; Xu W
    Mol Med Rep; 2018 Aug; 18(2):1820-1825. PubMed ID: 29901180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
    Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
    Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular changes to HeLa cells on continuous exposure to cisplatin or paclitaxel.
    Takara K; Obata Y; Yoshikawa E; Kitada N; Sakaeda T; Ohnishi N; Yokoyama T
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):785-93. PubMed ID: 16534613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and promoter methylation analysis of ATP-binding cassette genes in pancreatic cancer.
    Chen M; Xue X; Wang F; An Y; Tang D; Xu Y; Wang H; Yuan Z; Gao W; Wei J; Zhang J; Miao Y
    Oncol Rep; 2012 Jan; 27(1):265-9. PubMed ID: 21956451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
    Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multidrug resistance mechanisms in cell line HL-60/VCR].
    Zhu XH; Li JY; Xia XM; Zhu MQ; Geng MJ; Chen L; Zhang JQ
    Ai Zheng; 2002 Dec; 21(12):1310-3. PubMed ID: 12520737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of oxygen on multidrug resistance in the first trimester human placenta.
    Lye P; Bloise E; Dunk C; Javam M; Gibb W; Lye SJ; Matthews SG
    Placenta; 2013 Sep; 34(9):817-23. PubMed ID: 23790363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line.
    Wen J; Zheng B; Hu Y; Zhang X; Yang H; Luo KJ; Zhang X; Li YF; Fu JH
    Oncol Rep; 2009 Jul; 22(1):65-71. PubMed ID: 19513506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role and mechanism of Twist1 in modulating the chemosensitivity of FaDu cells.
    Lu S; Yu L; Mu Y; Ma J; Tian J; Xu W; Wang H
    Mol Med Rep; 2014 Jul; 10(1):53-60. PubMed ID: 24805866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse cross-resistance phenotype to ET-743 and PM00104 in multi-drug resistant cell lines.
    Duan Z; Choy E; Jimeno JM; Cuevas Cdel M; Mankin HJ; Hornicek FJ
    Cancer Chemother Pharmacol; 2009 May; 63(6):1121-9. PubMed ID: 18828019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of a cisplatin-induced multidrug resistance cell line SK-Hep1/DDP.
    Zhou Y; Ling XL
    Chin J Cancer; 2010 Feb; 29(2):167-71. PubMed ID: 20109345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and activity of the efflux transporters ABCB1, ABCC2 and ABCG2 in the human colorectal carcinoma cell line LS513.
    Salphati L; Plise EG; Li G
    Eur J Pharm Sci; 2009 Jun; 37(3-4):463-8. PubMed ID: 19491037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing multidrug-resistant cells and exploring correlation between BCRP/ABCG2 over-expression and DNA methyltransferase.
    Ji N; Yuan J; Liu J; Tian S
    Acta Biochim Biophys Sin (Shanghai); 2010 Dec; 42(12):854-62. PubMed ID: 21106767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.